Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

216 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
MLL translocations, histone modifications and leukaemia stem-cell development.
Krivtsov AV, Armstrong SA. Krivtsov AV, et al. Among authors: armstrong sa. Nat Rev Cancer. 2007 Nov;7(11):823-33. doi: 10.1038/nrc2253. Nat Rev Cancer. 2007. PMID: 17957188 Review.
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ. Armstrong SA, et al. Nat Genet. 2002 Jan;30(1):41-7. doi: 10.1038/ng765. Epub 2001 Dec 3. Nat Genet. 2002. PMID: 11731795
Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias.
Armstrong SA, Hsieh JJ, Korsmeyer SJ. Armstrong SA, et al. Curr Opin Hematol. 2002 Jul;9(4):339-44. doi: 10.1097/00062752-200207000-00012. Curr Opin Hematol. 2002. PMID: 12042709 Review.
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.
Stam RW, den Boer ML, Meijerink JP, Ebus ME, Peters GJ, Noordhuis P, Janka-Schaub GE, Armstrong SA, Korsmeyer SJ, Pieters R. Stam RW, et al. Among authors: armstrong sa. Blood. 2003 Feb 15;101(4):1270-6. doi: 10.1182/blood-2002-05-1600. Epub 2002 Oct 24. Blood. 2003. PMID: 12406912
Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.
Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, Den Boer ML, Pieters R, Kersey JH, Sallan SE, Fletcher JA, Golub TR, Griffin JD, Korsmeyer SJ. Armstrong SA, et al. Cancer Cell. 2003 Feb;3(2):173-83. doi: 10.1016/s1535-6108(03)00003-5. Cancer Cell. 2003. PMID: 12620411
Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.
Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ, Look AT. Ferrando AA, et al. Among authors: armstrong sa. Blood. 2003 Jul 1;102(1):262-8. doi: 10.1182/blood-2002-10-3221. Epub 2003 Mar 13. Blood. 2003. PMID: 12637319
Comparison of human genomics and genetic models of cancer to identify novel therapeutic targets.
Armstrong SA, Korsmeyer SJ. Armstrong SA, et al. Cell Cycle. 2003 Sep-Oct;2(5):408-9. Cell Cycle. 2003. PMID: 12963826 Review. No abstract available.
MLL-rearranged leukemias: insights from gene expression profiling.
Armstrong SA, Golub TR, Korsmeyer SJ. Armstrong SA, et al. Semin Hematol. 2003 Oct;40(4):268-73. doi: 10.1016/s0037-1963(03)00196-3. Semin Hematol. 2003. PMID: 14582077 Review.
FLT3 mutations in childhood acute lymphoblastic leukemia.
Armstrong SA, Mabon ME, Silverman LB, Li A, Gribben JG, Fox EA, Sallan SE, Korsmeyer SJ. Armstrong SA, et al. Blood. 2004 May 1;103(9):3544-6. doi: 10.1182/blood-2003-07-2441. Epub 2003 Dec 11. Blood. 2004. PMID: 14670924
Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.
Wang J, Iwasaki H, Krivtsov A, Febbo PG, Thorner AR, Ernst P, Anastasiadou E, Kutok JL, Kogan SC, Zinkel SS, Fisher JK, Hess JL, Golub TR, Armstrong SA, Akashi K, Korsmeyer SJ. Wang J, et al. Among authors: armstrong sa. EMBO J. 2005 Jan 26;24(2):368-81. doi: 10.1038/sj.emboj.7600521. Epub 2005 Jan 6. EMBO J. 2005. PMID: 15635450 Free PMC article.
216 results
Jump to page